Merit Medical Systems ( (MMSI) ) has provided an announcement.
Merit Medical Systems reported a strong Q3 2024, with revenue reaching $339.8 million, marking a 7.8% increase from the previous year. Their non-GAAP earnings per share saw a 21% rise, reflecting robust financial performance despite challenges. The company also completed strategic acquisitions and updated its full-year guidance, demonstrating confidence in continued growth and profitability. Investors can expect ongoing focus on improving margins and cash flow, with key acquisitions set to bolster their market position.
See more insights into MMSI stock on TipRanks’ Stock Analysis page.
